A superheated Na cell for X-ray photoionization experiments

Wisoff, P. J.; G., R.

doi:10.1007/bf00697424

Cited by 8 publications

(2 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fi g. 1 Incidenceof supraventricular tachyarrhythmiaonpostoperativedays (0ato D7)for thetwogroups Supraventricular tachya rr hythmia is a well-recognised occurrence in the early postope rative peri od following myocardial revascularisation , with a reported inciden ce between 10 and 40 % (3,9,10,13,15). The aetiology of the a rrhythmia is multifactorial and is probably partl y related to the adequ acy of revascu larisation and the methods of myocardial preservation .…”

Section: Introductionmentioning

confidence: 99%

“…Does Low-Dose Propranolol Reduce the Incidence of Supr aventr icular Tachyarrhythmias Following Myocardial Revascularisation? -A Clinical Study Introduction Supraventri cular tachyarrhythmia (SVfA) following coronary art ery bypass gra fting (CABG) is a n important cause of morbidity in the early postoperative period (15). Severa l reports have indicated that the incidence of these arrhyt hmias may be reduced by the routin e administra tion of prop ran olol (1 .4.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Does Low-Dose Propranolol Reduce the Incidence of Supraventricular Tachyarrhythmias Following Myocardial Revascularisation? - A Clinical Study

Shafei

Nashef²,

Turner³

et al. 1988

Thorac cardiovasc Surg

View full text Add to dashboard Cite

During 1986, 343 consecutive patients who underwent isolated coronary bypass grafting were given 10 mg of propranolol three times daily for six postoperative weeks to help prevent supraventricular tachyarrhythmias. The incidence of these arrhythmias in this group was compared to that in a similar group of 337 consecutive patients who underwent coronary surgery in 1984 at the same institution and did not receive propranolol. There was no significant difference in the overall incidence of such arrhythmias between the propranolol group (10.8%) and the control group (10.4%). In preoperatively beta-blocked patients, the arrhythmia incidence in the propranolol group (9.9%) was lower than that in the control group (13.8%) but the difference did not achieve statistical significance. The two groups were also similar with respect to the ventricular response rates at the onset of the arrhythmia and the effectiveness of therapeutic intervention. These results suggest that propranolol in the above dosage does not significantly reduce the incidence of supraventricular tachyarrhythmias after myocardial revascularisation.

show abstract

Section: Introductionmentioning

confidence: 99%

mentioning

confidence: 99%